Health
Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants – News-Medical.Net
A promising new study reports on the high neutralizing efficacy of a polyclonal swine antibody against SARS-CoV-2, the pathogen responsible for the novel COVID-19….
A promising new study, released as a preprint on the bioRxiv* server, reports on the high neutralizing efficacy of a polyclonal swine antibody against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the novel coronavirus disease 2019 (COVID-19). By demonstrating the ability of this antibody to neutralize all currently circulating viral variants, the study suggests that it is ideal for development as a new and very effective therapy for COVID-19.
Antibodies…
-
Business24 hours agoWhy these are 2 of the most exciting ASX 300 shares to buy right now
-
Noosa News23 hours agoInside the illegal tobacco trade —secret rooms, fire bombings and bags full of cash
-
Business21 hours agoThese ASX 200 shares could rise 15% to 20%
-
Business20 hours agoEvery ASX 200 sector closed in the red last week. Here’s why